C07D 237/32
With oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
Official title: with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
C07D237/32 (With oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring) appears on 312 US grants and 272 published applications in this corpus.
Search patents in C07D- Granted patents
- 312
- Published applications
- 272
- Assignees
- 183
- Inventors
- 1,003
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 6 | 0 |
| 1980 | 8 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 7 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 2 | 0 |
| 2000 | 6 | 0 |
| 2001 | 10 | 0 |
| 2002 | 10 | 9 |
| 2003 | 5 | 6 |
| 2004 | 6 | 9 |
| 2005 | 7 | 20 |
| 2006 | 3 | 6 |
| 2007 | 3 | 7 |
| 2008 | 6 | 18 |
| 2009 | 6 | 10 |
| 2010 | 10 | 12 |
| 2011 | 8 | 8 |
| 2012 | 11 | 11 |
| 2013 | 8 | 8 |
| 2014 | 7 | 23 |
| 2015 | 20 | 11 |
| 2016 | 11 | 21 |
| 2017 | 22 | 19 |
| 2018 | 9 | 12 |
| 2019 | 9 | 3 |
| 2020 | 4 | 11 |
| 2021 | 7 | 9 |
| 2022 | 5 | 6 |
| 2023 | 2 | 10 |
| 2024 | 6 | 7 |
| 2025 | 7 | 9 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the preparation of Olaparib, and crystalline form thereof8 Sep 2026US 12,729,184 B2Alivus Life Sciences Limited
- Radiolabelled compound18 Aug 2026US 12,709,601 B2Oxford University Innovation Limited
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Phthalazinone based modulators for the treatment of disease11 Nov 2025US 12,465,603 B2Soley Therapeutics, Inc.
- Nitrogen-containing heterocyclic compound having NRF2 activation effect14 Oct 2025US 12,441,735 B2Chugai Seiyaku Kabushiki Kaisha
- Small molecule inhibitors of the bfrb:bfd interaction20 Aug 2026US 2026/0240813 A1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists4 Jun 2026US 2026/0152484 A1Vigil Neuroscience, Inc.
- Phthalazine derivatives as pyruvate kinase modulators4 Jun 2026US 2026/0152487 A1Sitryx Therapeutics Limited
- Papd5 inhibitors and methods of use thereof30 Apr 2026US 2026/0115182 A1Children's Medical Center Corporation
- Phthalazinone compounds as parp7 inhibitors26 Feb 2026US 2026/0055079 A1Azkarra Therapeutics, Inc.
Most cited
By later US patents
- Heterogenous specific binding assay employing a cycling reactant as label151US 4,318,980 AMiles Laboratories, Inc. · 1982
- Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process91US 5,177,075 AWarner-Lambert Company · 1993
- Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity78US 6,121,278 AGuilford Pharmaceuticals Inc. · 2000
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004
- PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same77US 6,635,642 B1Guilford Pharmaceuticals Inc. · 2003